Trial intelligence / Profile preview

Melatonin Supplementation in Ovarian Response for Infertile Women

NCT07343947Completed

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Jan 2022
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in infertility comparing Melatonin 5mg with Placebo (2 arms). Primary endpoint: Follicular fluid melatonin concentration at 7 weeks. Started Jan 2022; status: completed.

02

Drugs

melatonin
03

Conditions

infertility

Beyond the preview

Go deeper on NCT07343947.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07343947.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call